VYGR News and Press, Voyager Therapeutics Inc. From 11/06/23

Voyager Therapeutics Inc. (VYGR) is expected to report $-0.58 for Q3 2023

2023-11-05 17:35:55 ET Major earnings expected after the bell on Monday include: Realty Income Corporation ( O ) Vertex Pharmaceuticals Incorporated ( VRTX ) NXP Semiconductors N.V. ( NXPI ) Alteryx ( AYX ) Tanger Factory Outlet Centers ( SKT ) ...

2023-11-03 12:46:55 ET More on Voyager Therapeutics Assessing Voyager's Alzheimer's Treatment Potential Seeking Alpha’s Quant Rating on Voyager Therapeutics Historical earnings data for Voyager Therapeutics Financial information for Voyager Therapeutic...

CAMBRIDGE, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report third quarter 2023 financial and operating results after market close on Monda...

2023-10-05 17:23:44 ET Gainers: nCino ( NASDAQ: NCNO ) +8% . TPI Composites ( TPIC ) +6% . SCYNEXIS ( SCYX ) +5% . Sutro Biopharma ( STRO ) +5% . Black Diamond Therapeutics ( BDTX ) +4% . Losers: SomaLogic ( SLGC ...

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Executive Officer Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the Char...

2023-09-22 20:11:04 ET Summary Voyager Therapeutics shows strong financials with $272.8M liquidity and $4.9M Q2 collaboration revenue, yet R&D spending signals higher risk. The company's Alzheimer's gene therapies via TRACER technology are promising but in early stages, warran...

2023-08-07 13:47:21 ET Summary Two new Breakout Stocks for Week 32 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks cleared the 10% mark in less than a week with peak gains in PLTR +18.0% and ARDX +13.1%. The Momen...

CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of Beth Shafer, Ph.D., M.A., M.Phil., as Chief Business Officer (CBO). ...

2023-08-03 13:26:09 ET Start Time: 08:30 End Time: 09:08 Voyager Therapeutics, Inc. (VYGR) Q2 2023 Earnings Conference Call August 03, 2023, 08:30 AM ET Company Participants Al Sandrock - President and CEO Pete Pfreundschuh - CFO Todd Carter - Chief Scien...